Medtronic recently began a clinical study to evaluate the safety and effectiveness of the Endurant Evo abdominal aortic aneurysm (AAA) stent graft system, an investigational medical device designed to expand the applicability of a minimally invasive alternative to open surgical repair for the treatment of abdominal aortic aneurysms.
Spectranetics is accelerating investments in the Stellarex drug-coated balloon angioplasty platform for treatment of below-the-knee peripheral artery disease. The company estimates this will represent a $150m market opportunity by 2020.
Medtronic has announced the start of a new feasibility study to evaluate the safety and effectiveness of the Valiant Mona LSA branch thoracic stent graft system, an investigational medical device designed to enable a completely endovascular solution for aortic aneurysms encroaching on the left subclavian artery.
Cardiovascular Systems has received FDA clearance for the new 4 French (4 Fr) 1.25 Solid Diamondback 360 peripheral orbital atherectomy system for the treatment of peripheral artery disease.
Contego Medical, the first and only provider of the Integrated Embolic Protection filter platform for angioplasty balloon and stent delivery catheters, announces the completion of a US$5.6 million Series B financing round led by Hatteras Venture Partners. The round also included Mountain Group Partners, Lookout Capital and Medical Mutual.
The second day of the CX Venous Workshop was held yesterday on the Upper Level of the Gallery, rounding off a busy week in which more than 950 people visited over the two days—a new record for the Workshop. Once again the educational stations, of which there were more than 30, were packed with delegates looking forward to one-on-one time with the distinguished Charing Cross Symposium faculty.
Yesterday saw the beginning of the two-day CX Venous Workshop, in which delegates can enjoy expert demonstrations of a selection of the most interesting and important phlebological technologies currently in use. Now in its seventh year, the event continues to attract more and more delegates to its plethora of new and established technologies, and this year occupied its largest space ever on the Upper Level of the Gallery. The first day of the workshop largely focused on varicose vein treatment and superficial venous issues.
Hansen has announced the completion of the world’s first clinical procedure with the Magellan 10F robotic catheter. Interventional radiologist Gerard Goh performed the procedure at The Alfred Hospital in Melbourne, Australia. He used the 10F catheter during a robot-assisted placement of an inferior vena cava filter.
Lombard Medical has announced the enrolment and treatment of the first patient in the ARCHYTAS global registry. An 89-year-old male with a 64mm aneurysm and challenging 75-degree aortic neck angulation was treated with Lombard Medical’s Aorfix endovascular stent graft in Girona, Spain.
EndoShape has announced that it has been selected to present at the Cavendish Global Health Impact Forum taking place 10–14 May in La Jolla, USA. -
Quiremspheres, that were developed by the University Medical Center (UMC) Utrecht, The Netherlands, to be used in a new treatment for liver cancer, have received the European CE mark for quality and safety. The treatment is being marketed by Quirem Medical, a spin-off company of the UMC Utrecht.
Surefire Medical has announced that the company’s new Precision targeted delivery infusion system, for direct-to-tumour embolization procedures, has received the CE mark from European regulators. Surefire infusion systems are today used primarily in treating inoperable liver cancers, although clinical trials are under way for additional medical conditions.
VesselNavigator has been designed for use in conjunction with Philips’ interventional X-ray systems to guide catheters during treatment of vascular disease. The new system allows for a major reduction of contrast medium (70%) demonstrated in clinical study, enabling minimally invasive treatment of aortic aneurysms in a number of patients who are currently unable to benefit from minimally-invasive techniques.
Micro-mesh stents and sustained anti-embolic action to reduce cerebral embolisation may contribute to solving the remaining limitations of carotid stenting, according to Alberto Cremonesi (Cotignola, Italy), who spoke at CX 2015 (28 April–1 May, London, UK).
Yasuaki Arai, director of the National Cancer Center Hospital, Tokyo, Japan, and current president of the Japanese Society of Interventional Radiology (JSIR), delivered the Honorary Lecture at the European Conference of Interventional Oncology (ECIO) in Nice, France, yesterday. He spoke on the topic “Beyond the evidence—the true goal of interventional oncology” and received a standing ovation for his presentation.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos